Efficacy of the ketogenic diet in the 6-Hz seizure test

Area of Science:

• Neuroscience
• Metabolic Disorders
• Pharmacology

Background:

• The ketogenic diet is recognized for its efficacy in managing drug-resistant epilepsies.
• Conventional antiepileptic screening tests may not capture the full spectrum of anticonvulsant activity.
• The 6-Hz seizure test offers a broader screening platform for potential antiepileptic agents.

Purpose of the Study:

• To evaluate the ketogenic diet's efficacy in the 6-Hz seizure test.
• To determine if the ketogenic diet exhibits anticonvulsant properties beyond established drug-resistant epilepsy models.
• To assess the 6-Hz seizure test's ability to identify agents with broader antiepileptic activity.

Main Methods:

• Male NIH Swiss mice (3-4 weeks old) were fed either a normal or ketogenic diet for 2-21 days.
• The corneal stimulation current intensity required to elicit seizures in the 6-Hz test (CC50) was measured.
• Blood glucose and beta-hydroxybutyrate levels were quantified on the day of seizure testing.

Main Results:

• The ketogenic diet significantly elevated the CC50 to 50.6 mA after 12 days, compared to 15 mA for the normal diet (p < 0.001).
• Elevated CC50 was observed after 16 days of ketogenic diet, but not after 2, 5, or 21 days, indicating a time-specific effect.
• Ketogenic diet-fed mice showed higher beta-hydroxybutyrate and lower glucose levels, but these did not correlate with CC50.
• CC50 did not vary with body weight in mice on a normal diet, suggesting the 6-Hz model is not confounded by weight changes.

Conclusions:

• The ketogenic diet demonstrates a time-dependent increase in seizure threshold within the 6-Hz seizure test.
• Anticonvulsant effects in this model are not directly correlated with the level of ketosis.
• The 6-Hz seizure test is a valuable tool for assessing anticonvulsant regimens, as it is insensitive to body weight variations.